Nostopharma
1 known investors
Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.
BiotechHealthtechMedical Devices
Investors · 1
In the news
- TEDCO Invests in Nostopharma | citybizcitybiz.co · 2025
- Nostopharma - 2026 Company Profile, Team, Funding & Competitors - Tracxntracxn.com · 2023
- Nostopharma Using LSN and RESI Navigate A Seed Roundblog.lifesciencenation.com · 2020
- NCC-PDI Announces Finalists in $250K Pediatric Pitch Competition - WFMJ.com News weather sports for Youngstown-Warren Ohiowfmj.com · 2019